Average Co-Inventor Count = 2.24
ph-index = 13
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Eli Lilly and Company (74 from 4,442 patents)
74 patents:
1. 8476300 - Selective estrogen receptor modulator for the treatment of osteoarthritis
2. 8217032 - Selective estrogen receptor modulators for the treatment of vasomotor symptoms
3. 7585977 - Selective estrogen receptor modulators containing a phenylsulfonyl group
4. 7501441 - Naphthyl compounds, intermediates, processes, compositions, and methods
5. 7462647 - Pentalfluoroalkanesulfinyl naphthalenes and related estrogen receptor modulators
6. 7217734 - Substituted benzopyrans as selective estrogen receptor-beta agonists
7. 7125840 - Substituted dipeptides as growth hormone secretagogues
8. 6992097 - Growth hormone secretagogues
9. 6828331 - Growth hormone secretagogues
10. 6723739 - Glucopyranoside benzothiophenes
11. 6703407 - Benzofuran compounds, compositions, and methods
12. 6639076 - Growth hormone secretagogues
13. 6630508 - Substituted benzopyrans as selective estrogen receptor &bgr; agonists
14. 6608090 - Benzothiophenes with novel basic side chains
15. 6509356 - 1-(4-(Substituted alkoxy)benzyl)naphthalene compounds having estrogen inhibitory activity